5:00 – 6:00
Registration & Networking
6:00 – 6:05
Welcome and Opening Remarks
Bob Buderi, Xconomy
6:10 – 6:40
The RDMD Story
Sparked from a Silicon Valley hackathon, RDMD is building repositories of patient health data to encourage new drugs for rare diseases.
Introduction: Tiffany Reiter, Fish & Richardson
6:45 – 7:15
The Cortexyme Story
With more than $90 million in funding, drug developer Cortexyme thinks bacteria in the brain could be at play with Alzheimer’s and other neurodegenerative diseases.
Casey Lynch, Cortexyme
7:15 – 7:45
The Allogene Therapeutics Story
Allogene is developing what it hopes will be more affordable cancer cell therapies for a wider range of cancer patients, made from donor cells rather than a patient’s own T cells.
Arie Belldegrun, Allogene Therapeutics
7:45 – 8:45
Please note that this schedule is subject to change.